Paydirt
CG
Insider

Christopher Gibson

Director

Christopher Gibson (Director) filed 17 Form 4 reports in the trailing twelve months (0 purchases, 17 sales), most often in Recursion Pharmaceuticals, Inc. (RXRX). The largest single filing was $604K of RXRX (100,000 sh × $6.04, as filed), executed Oct 10 2025.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
17
0 buys · 17 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$3.4M
shares × price, as filed
Last traded
Jun 5
Filed Jun 5

Median ADV $67.5M across their filed names

Open performance
Volume by month
$3.7M$1.8M$0Oct 2024Apr 2025Oct 2025Apr 2026Oct 2024 · sells $245KNov 2024 · sells $302KDec 2024 · sells $286KJan 2025 · sells $287KFeb 2025 · sells $316KMar 2025 · sells $1.1MAug 2025 · sells $3.7MSep 2025 · sells $947KOct 2025 · sells $1.2MNov 2025 · sells $375KDec 2025 · sells $365KJan 2026 · sells $349KFeb 2026 · sells $303KMar 2026 · sells $130KApr 2026 · sells $268KMay 2026 · sells $258KJun 2026 · sells $145K
Buys $0 Sells $10.5M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 17 filings

Sector per market data · by filing · past 12 months

Most traded names
RXRX Recursion Pharmaceuticals, Inc. RXRX · 0 buys · 27 sells 27 filings
Recent filings
RXRXSALE Recursion Pharmaceuticals, Inc. View filing → $179K
40,000 sh × $4.47
Exec Jan 20
Filed Jan 22 · 5:30 PM ET
RXRXSALE Recursion Pharmaceuticals, Inc. View filing → $170K
40,000 sh × $4.25
Exec Jan 5
Filed Jan 7 · 5:30 PM ET
RXRXSALE Recursion Pharmaceuticals, Inc. View filing → $180K
40,000 sh × $4.50
Exec Dec 19 2025
Filed Dec 19 2025 · 5:30 PM ET
RXRXSALE Recursion Pharmaceuticals, Inc. View filing → $185K
40,000 sh × $4.63
Exec Dec 4 2025
Filed Dec 5 2025 · 5:30 PM ET
RXRXSALE Recursion Pharmaceuticals, Inc. View filing → $166K
40,000 sh × $4.16
Exec Nov 19 2025
Filed Nov 19 2025 · 5:30 PM ET
RXRXSALE Recursion Pharmaceuticals, Inc. View filing → $208K
40,000 sh × $5.21
Exec Nov 4 2025
Filed Nov 6 2025 · 5:30 PM ET
RXRXSALE Recursion Pharmaceuticals, Inc. View filing → $570K
100,000 sh × $5.70
Exec Oct 23 2025
Filed Oct 24 2025 · 5:30 PM ET
RXRXSALE Recursion Pharmaceuticals, Inc. View filing → $604K
100,000 sh × $6.04
Exec Oct 10 2025
Filed Oct 10 2025 · 5:30 PM ET
More filings →